BEVACIZUMAB AMRING PHARMA 400MG/16ML – 1

Bevacizumab Amring 400 mg/16 mL is a monoclonal antibody used primarily in the treatment of various types of cancer. It works by inhibiting vascular endothelial growth factor (VEGF), which is crucial for tumor angiogenesis—the formation of new blood vessels that supply nutrients to tumors.

The drug is commonly used in the treatment of metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. By blocking VEGF, Bevacizumab helps to slow down tumor growth and progression, improving patient outcomes.

In addition to its oncological applications, Bevacizumab is also used in ophthalmology for conditions like age-related macular degeneration, where it helps reduce abnormal blood vessel growth in the eye. Overall, Bevacizumab Amring is a vital component in cancer therapy and certain eye diseases, enhancing the effectiveness of treatment regimens.